Internal Medicine, Allergy & Immunology · Boston, MA
NPI
1851588693
Since 2007
Specialty
Internal Medicine, Allergy & Immunology
Code 207RA0201X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
55 Fruit St, Cox 201
Boston, MA, 02114
Phone (617) 726-3850
Groups this clinician bills Medicare through
Medicare paid, 2024
$107K
7,435 services
Medicare patients, 2024
2,992
Average age 74
Drug cost, 2024
$408K
554 prescriptions
Company payments, 2024
$185
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Morris Ling was code 86320 (immunoassay), 2,835 times for 2,009 patients. In total Morris Ling billed 7,435 services in 28 codes, and Medicare paid $107K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 86320 Immunoassay | Facility | 2,835 | 2,009 | $13.02 | $37K |
| 86334 Immunoassay | Facility | 980 | 829 | $13.43 | $13K |
| 95004 Test - Miscellaneous | Office | 795 | 28 | $3.24 | $2,572 |
| 86325 Immunoassay | Facility | 563 | 390 | $13.34 | $7,508 |
| 95024 Test - Miscellaneous | Office | 558 | 20 | $7.29 | $4,066 |
| 86256 Immunoassay | Facility | 420 | 415 | $12.60 | $5,290 |
| 86255 Immunoassay | Facility | 365 | 361 | $14.34 | $5,233 |
| 89060 Test - Miscellaneous | Facility | 156 | 129 | $13.87 | $2,164 |
| 95117 Treatment - Miscellaneous | Office | 129 | 43 | $10.55 | $1,361 |
| 99214 Office E&M - Established | Office | 94 | 83 | $101.62 | $9,552 |
| 99204 Office E&M - New | Office | 49 | 49 | $120.81 | $5,920 |
| 95115 Treatment - Miscellaneous | Office | 41 | 12 | $7.95 | $326 |
| 99215 Office E&M - Established | Office | 30 | 22 | $155.99 | $4,680 |
| 99205 Office E&M - New | Office | 11 | 11 | $172.47 | $1,897 |
By year: 2022 $98K for 7,140 services; 2023 $105K for 6,589 services; 2024 $107K for 7,435 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86320 Immunoassay | 2,835 | 2,009 | $13.02 | $37K |
| 86334 Immunoassay | 980 | 829 | $13.43 | $13K |
| 86325 Immunoassay | 563 | 390 | $13.34 | $7,508 |
| 86256 Immunoassay | 420 | 415 | $12.60 | $5,290 |
| 86255 Immunoassay | 365 | 361 | $14.34 | $5,233 |
Medicare prescription drug claims, 2024
In 2024, the drug Morris Ling prescribed most often to Medicare patients was Dupixent Syringe (Dupilumab), with 63 prescriptions and refills. In total Morris Ling wrote 554 Medicare prescriptions that cost $408K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Syringe Dupilumab | 63 | 63 | Under 11 | $278K |
| Montelukast Sodium Generic | 51 | 122 | 14 | $1,233 |
| Azelastine Hcl Generic | 47 | 124 | 25 | $1,861 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 34 | 40 | 11 | $902 |
| Pulmicort Flexhaler Budesonide | 30 | 34 | Under 11 | $8,201 |
| Cromolyn Sodium Generic | 28 | 37 | Under 11 | $14K |
| Epinephrine Generic | 24 | 24 | 19 | $3,771 |
| Ipratropium Bromide Generic | 22 | 39 | Under 11 | $1,161 |
| Famotidine Generic | 21 | 64 | Under 11 | $640 |
| Symbicort Budesonide/Formoterol Fumarate | 21 | 21 | Under 11 | $4,554 |
| Fluticasone Propionate Generic | 20 | 47 | Under 11 | $400 |
| Breo Ellipta Fluticasone/Vilanterol | 18 | 20 | Under 11 | $7,511 |
| Odactra Mite,d.Farinae-D.Pteronyssinus | 16 | 26 | Under 11 | $9,039 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 16 | 22 | Under 11 | $1,211 |
| Ventolin Hfa Albuterol Sulfate | 14 | 14 | Under 11 | $717 |
Brand drugs: 277 claims; generic drugs: 277 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Morris Ling $185 ($185 in general payments such as food, travel and fees) from 1 company. The largest payer was Werfen USA LLC with $185.
| Company | Payments | Amount |
|---|---|---|
| Werfen USA LLC | 2 | $185 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.